| Net income (loss) | 52.21M |
| Income from discontinued operations, net of taxes | -53.48M |
| Bad debt expense | 30.48M |
| Depreciation | 12.09M |
| (Gain) loss on disposal of property, equipment and other assets | -141K |
| Share-based compensation expense | 3.28M |
| Gain on sale of unconsolidated affiliates | -15.39M |
| Amortization of loan acquisition costs | 1.1M |
| Impairment of long-lived assets | 20.36M |
| Equity in earnings of unconsolidated affiliates, net of distributions received | -583K |
| Deferred income taxes | -11.59M |
| Accounts receivable | -32.77M |
| Medical supplies | 202K |
| Prepaid and other assets | 5.06M |
| Accounts payable and accrued liabilities | -7.22M |
| Net cash provided by operating activities of continuing operations | 3.63M |
| Net cash (used in) provided by operating activities of discontinued operations | -16.63M |
| Net cash (used in) provided by operating activities | -13M |
| Purchases of property and equipment | -2.3M |
| Proceeds from sale of property and equipment | 281K |
| Changes in restricted cash | 1.77M |
| Proceeds from sale of unconsolidated affiliates | 24.85M |
| Net cash provided by (used in) investing activities of continuing operations | 21.07M |
| Net cash provided by (used in) investing activities of discontinued operations | 232.47M |
| Net cash provided by (used in) investing activities | 253.53M |
| Repayments of long-term debt | -66.56M |
| Repayments of obligations under capital leases | -1.87M |
| Distributions to noncontrolling interest | -7.38M |
| Investment by noncontrolling interest | 0 |
| Sale of equity interest in subsidiary | 0 |
| Tax withholding of vested restricted stock awards | -2.49M |
| Net cash used in financing activities of continuing operations | -78.31M |
| Net cash used in financing activities of discontinued operations | -52.39M |
| Net cash used in financing activities | -130.69M |
| Net increase (decrease) in cash and cash equivalents | 109.84M |
| Beginning of period | 47.03M |
| End of period | 156.87M |
| Cash and cash equivalents of continuing operations | 113.67M |
| Cash and cash equivalents of discontinued operations | 43.2M |